Drug Type Biological products |
Synonyms- |
Target |
Mechanism CHI3L1 inhibitors(chitinase 3 like 1 inhibitors), PD-1 modulators(Programmed cell death protein 1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | US | 06 Sep 2022 | |
Melanoma | Preclinical | US | 06 Sep 2022 |